Troy A. Ignelzi, Chief Financial Officer

KRTX 0 shares

The estimated Net Worth of Troy A. Ignelzi is at least $0.00. Troy A. Ignelzi owns over 0 units of Karuna Therapeutics, Inc. stock worth over $0.00.

Transaction DateCompanySharesTypeOwnedPriceValuePost Value
2nd March 2020KRTX - Karuna Therapeutics, Inc.7,500Open or private sale0$86.50$648,750.00$0.00
2nd March 2020KRTX - Karuna Therapeutics, Inc.7,500Exercise of derivative7,500$9.20$69,000.00$69,000.00
8th May 2020KRTX - Karuna Therapeutics, Inc.7,500Open or private sale0$83.38$625,350.00$0.00
8th May 2020KRTX - Karuna Therapeutics, Inc.7,500Exercise of derivative7,500$9.20$69,000.00$69,000.00
16th June 2020KRTX - Karuna Therapeutics, Inc.2,000Open or private sale0$100.00$200,000.00$0.00
16th June 2020KRTX - Karuna Therapeutics, Inc.2,000Exercise of derivative2,000$9.20$18,400.00$18,400.00
15th June 2020KRTX - Karuna Therapeutics, Inc.4,000Open or private sale0$89.62$358,480.00$0.00
15th June 2020KRTX - Karuna Therapeutics, Inc.4,000Exercise of derivative4,000$9.20$36,800.00$36,800.00
15th June 2020KRTX - Karuna Therapeutics, Inc.2,000Open or private sale0$90.00$180,000.00$0.00
15th June 2020KRTX - Karuna Therapeutics, Inc.2,000Exercise of derivative2,000$9.20$18,400.00$18,400.00
8th July 2020KRTX - Karuna Therapeutics, Inc.2,000Open or private sale0$100.00$200,000.00$0.00
8th July 2020KRTX - Karuna Therapeutics, Inc.6,000Open or private sale2,000$98.32$589,920.00$196,640.00
8th July 2020KRTX - Karuna Therapeutics, Inc.2,000Exercise of derivative8,000$9.20$18,400.00$73,600.00
8th July 2020KRTX - Karuna Therapeutics, Inc.6,000Exercise of derivative6,000$9.20$55,200.00$55,200.00
25th August 2020KRTX - Karuna Therapeutics, Inc.5,000Exercise of derivative5,000$9.20$46,000.00$46,000.00
8th September 2020KRTX - Karuna Therapeutics, Inc.2,000Open or private sale5,000$73.30$146,600.00$366,500.00
8th September 2020KRTX - Karuna Therapeutics, Inc.2,000Exercise of derivative7,000$9.20$18,400.00$64,400.00